Refoxy raises millions to advance FOXO3 ageing therapies
Longevity Technology - 04-Dec-2024Pioneering treatments target underlying mechanisms of age-related diseases like pulmonary fibrosis
Join the club for FREE to access the whole archive and other member benefits.
Pioneering treatments target underlying mechanisms of age-related diseases like pulmonary fibrosis
Drug improved chronic cough symptoms, contributing to a better quality of life\
Transforming respiratory care and reducing reliance on organ donors
Phase 2a trial results show positive outcomes among pulmonary fibrosis patients
The drug targets the lungs and activates stem cells
Click on resource name for more details.
No blog posts found!